Content about CITY

October 14, 2011

NBA star Carmelo Anthony, now the new corporate spokesman for ethnic hair care company Johnson Products Co., made a rare personal appearance on behalf of JPC’s new men’s grooming line, Ultra Sheen Men, at a Walmart supercenter in Union City, Ga., on Sept. 17.

UNION CITY, Ga. — NBA star Carmelo Anthony, now the new corporate spokesman for ethnic hair care company Johnson Products Co., made a rare personal appearance on behalf of JPC’s new men’s grooming line, Ultra Sheen Men, at a Walmart supercenter in Union City, Ga., on Sept. 17.

During the debut of CarmeloLIVE, customers were able to meet Anthony in person and had the opportunity to win prizes and receive free haircuts at the Ultra Sheen Men Grooming Lounge.

October 6, 2011

Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.

FOSTER CITY, Calif., and INGELHEIM, Germany — Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.

Under the terms of the agreement, Gilead will pay the German drug maker an upfront payment and possibly will receive additional payments based upon the achievement of certain development, regulatory and commercial milestones, as well as royalties on future net sales, the companies said.

October 6, 2011

Harris Teeter and Washington, D.C., Ward 6 council member Tommy Wells joined forces Thursday to offer a $10,000 donation to Jan’s Tutoring House, a nonprofit organization in Washington, D.C., that pairs children with volunteers who provide one-on-one tutoring and mentoring.

CHARLOTTE, N.C. — Harris Teeter and Washington, D.C., Ward 6 council member Tommy Wells joined forces Thursday to offer a $10,000 donation to Jan’s Tutoring House, a nonprofit organization in Washington, D.C., that pairs children with volunteers who provide one-on-one tutoring and mentoring.

September 15, 2011

The use of over-the-counter medicines as a cost savings tool is catching on, of all places, at the Centers for Medicare and Medicaid.

REDWOOD CITY, Calif. — The use of over-the-counter medicines as a cost savings tool is catching on, of all places, at the Centers for Medicare and Medicaid. Certain plans under Medicare are utilizing a new prepaid card of sorts to allow members to pay for their OTC medicines. Medicaid administrators, meanwhile, are employing that same card to incentivize healthier behavior among its members.

September 15, 2011

A value-based benefits project saved a group of employers in Kansas City, Mo., nearly $11 million in direct healthcare costs.

KANSAS CITY, Mo. — A value-based benefits project saved a group of employers in Kansas City, Mo., nearly $11 million in direct healthcare costs.

The Kansas City Collaborative, or KC2, launched a project focused on giving employees and their dependents access to better health information, reducing barriers to preventive care, engaging them in reducing health risks and accessing earlier treatment of chronic disease. Led by the Mid-America Coalition on Health Care, the project included 15 local employers and about 400,000 area employees and their dependents.

September 8, 2011

Walmart is gearing up to open a Neighborhood Market store this month in Midwest City, Okla.

MIDWEST CITY, Okla. — Walmart is gearing up to open a Neighborhood Market store this month in Midwest City, Okla.

The 40,000-sq.-ft. format will offer customers quick access to low-cost groceries, prescriptions and household products. The store officially will open its doors on Sept. 21.

As previously reported, Walmart president and CEO Bill Simon said that the Neighborhood Market format is being rebranded as Walmart Market.

August 16, 2011

A take-home allergy test called MyAllergyTest will be available beginning Oct. 1 in retail markets in the Midwest through a partnership between supplier ImmuneTech and Meijer, ImmuneTech announced Tuesday.

FOSTER CITY, Calif. — A take-home allergy test called MyAllergyTest will be available beginning Oct. 1 in retail markets in the Midwest through a partnership between supplier ImmuneTech and Meijer, ImmuneTech announced Tuesday.

MyAllergyTest provides customers with the ability to conduct a personal allergy test in the privacy of their own home. Once diagnosed, consumers are better able to self manage their allergies.

August 11, 2011

The Food and Drug Administration has approved a new single-pill treatment for HIV made by Gilead Sciences and Johnson & Johnson, Gilead said.

FOSTER CITY, Calif. — The Food and Drug Administration has approved a new single-pill treatment for HIV made by Gilead Sciences and Johnson & Johnson, Gilead said.

Gilead announced the approval of Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate). The drug combines Gilead's Truvada with J&J's Edurant.

August 10, 2011

GelStat Corp. on Tuesday announced it has retained Scarsdale Equities as its financial adviser to explore various strategic alternatives.

PALM CITY, Fla. — GelStat Corp. on Tuesday announced it has retained Scarsdale Equities as its financial adviser to explore various strategic alternatives.

"The company is in the final stages of its restructuring that began in 2008 and the timing is optimal for us to fully analyze all of our strategic options," stated Gerald Kieft, CEO of GelStat Corp.

August 10, 2011

Sunsweet Growers has acquired a maker of dietary supplement beverages.

YUBA CITY, Calif. — Sunsweet Growers has acquired a maker of dietary supplement beverages.

August 5, 2011

The Chain Drug Marketing Association recently announced that the debut of its “Make More Money Table Top Show” will take place in Philadelphia from Sept. 23 to 24.

NOVI, Mich. — The Chain Drug Marketing Association recently announced that the debut of its “Make More Money Table Top Show” will take place in Philadelphia from Sept. 23 to 24. The show will provide CDMA-member regional drug chains, regional drug wholesalers and independent pharmacies an opportunity to preview table-top displays of CDMA's hot items, with items from various categories, including seasonal, health-and-beauty and soft goods, among others. 

June 27, 2011

This fall, an acclaimed film trilogy is making its Blu-ray debut.

UNIVERSAL CITY, Calif. — This fall, an acclaimed film trilogy is making its Blu-ray debut.

The cinematic franchise "Jurassic Park," which includes the namesake film along with "The Lost World: Jurassic Park" and "Jurassic Park III," will be available Oct. 25 in a limited-edition Blu-ray set.

May 6, 2011

The blood test recommended for detecting Type 2 diabetes in overweight children may not be enough, and they may need two different tests to diagnose the disease, according to research conducted at Children's Mercy Hospital and Clinics in Kansas City, Mo.

KANSAS CITY, Mo. — The blood test recommended for detecting Type 2 diabetes in overweight children may not be enough, and they may need two different tests to diagnose the disease, according to research conducted at Children's Mercy Hospital and Clinics in Kansas City, Mo.

The researchers found that the hemoglobin A1C test missed more than two-thirds of diabetes cases in children at high risk for the condition, but they found that performing that test along with the oral glucose tolerance test dramatically could lower the risk of delayed diagnosis in overweight children.

May 4, 2011

Walgreens announced that it has partnered with NBCUniversal Television Consumer Products to launch an exclusive line of “The Biggest Loser”-branded meal alternative bars and shakes.

UNIVERSAL CITY, Calif. — Walgreens announced that it has partnered with NBCUniversal Television Consumer Products to launch an exclusive line of “The Biggest Loser”-branded meal alternative bars and shakes.

According to a company press release, the line of products, named for the popular NBC weight-loss reality show, will be offered in all of the more than 7,600 Walgreens stores nationwide beginning in May.

April 26, 2011

Hallmark is touting postage-paid greeting cards for Mother's Day.

KANSAS CITY, Mo. — Hallmark is touting postage-paid greeting cards for Mother's Day.

The greeting card maker said it has developed 90 postage-paid greetings specifically for Mother's Day, ranging from $2.69 to $3.99.

Hallmark postage-paid greetings feature the U.S. Postal Service's Intelligent Mail bar code on the front of the envelope, the company said. When the cards are processed at a Postal Service facility, the bar code automatically indicates to the Postal Service that the postage is paid.

Hallmark cards are available in retailers nationwide.

April 25, 2011

Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

REDWOOD CITY, Calif. — Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

AP announced the appointment of John Whelan as president, CEO and director, and Michael Adam as SVP and COO.

April 15, 2011

The main trade group representing branded drug makers gave an award to two Merck scientists who helped discover an oral medication for Type 2 diabetes.

JERSEY CITY, N.J. — The main trade group representing branded drug makers gave an award to two Merck scientists who helped discover an oral medication for Type 2 diabetes.

March 14, 2011

Drug maker Gilead acknowledged the receipt of an unsolicited mini-tender offer by TRC Capital.

FOSTER CITY, Calif. — Drug maker Gilead acknowledged the receipt of an unsolicited mini-tender offer by TRC Capital.

Gilead said that TRC seeks to purchase up to 3 million shares of the company at a price of $37.25 per share, or about $111.75 million. The drug maker said it is recommending shareholders reject the bid, stating that the offer is priced below the current market price for Gilead shares and is subject to numerous conditions. As of March 2, TRC's offer price represented approximately a 4.56% discount to the $39.03 closing price of Gilead common stock.

March 9, 2011

FRS Healthy Energy on Tuesday announced the launch of new Healthy Protein and Healthy Energy formulas to be shipped in April.

FOSTER CITY, Calif. — FRS Healthy Energy on Tuesday announced the launch of new Healthy Protein and Healthy Energy formulas to be shipped in April.

Both products will be fueled by the patented FRS quercetin formula, the company said. Quercetin, recently granted GRAS — generally recognized as safe — status by the Food and Drug Administration, is the natural energy-boosting antioxidant contained in all FRS products. To date, FRS Healthy Energy products contain the highest level of quercetin (QU995) on the market, the company claimed.

March 4, 2011

Gilead on Friday announced that the Food and Drug Administration has removed a boxed warning about a possible liver injury risk caused by the drug maker's hypertension treatment.

FOSTER CITY, Calif. — Gilead on Friday announced that the Food and Drug Administration has removed a boxed warning about a possible liver injury risk caused by the drug maker's hypertension treatment.

Gilead said the FDA approved a change to the prescribing information for Letairis (ambrisentan 5-mg and 10-mg tablets), the company’s once-daily treatment of pulmonary arterial hypertension.

March 4, 2011

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight Nasal Breathe Aid — a snore-relieving product entry into the nasal strip category that retails for a suggested $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each SleepRight Breathe Aid lasts up to 15 days. 

February 23, 2011

Drug maker Gilead Sciences plans to buy out a privately owned Seattle company that makes treatments for cancer and inflammatory diseases, Gilead said Tuesday.

FOSTER CITY, Calif. — Drug maker Gilead Sciences plans to buy out a privately owned Seattle company that makes treatments for cancer and inflammatory diseases, Gilead said Tuesday.

The Foster City, Calif.-based company will buy Calistoga Pharmaceuticals for $375 million, plus additional milestone payments of up to $225 million.

February 23, 2011

Splintek Health Products recently launched its SleepRight nasal breathe aide — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

KANSAS CITY, Mo. — Splintek Health Products recently launched its SleepRight nasal breathe aid — a snore-relieving product entry into the nasal strip category that retails for a suggested price of $11.99.

According to the company, the product reduces snoring, relieves nasal congestion and is adhesive-free and reusable. Flexible flares expand the nasal passages to significantly increase airflow, while forming to the shape of the user’s nose for a custom, comfortable fit. Each breathe aid is reusable and lasts up to 15 days.

February 17, 2011

Hallmark has partnered with the U.S. Postal Service to make sending greeting cards hassle-free.

KANSAS CITY, Mo. — Hallmark has partnered with the U.S. Postal Service to make sending greeting cards hassle-free.

New postage-paid greetings, which will range in price from $2.69 to $3.99, feature the U.S. Postal Service's Intelligent Mail bar code on the front of the envelope. Acting as a first-class stamp, Hallmark's postage-paid greetings have an added convenience so consumers can sign, seal and send cards without worrying about adding a stamp to the envelope.

February 14, 2011

Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

FOSTER CITY, Calif. — Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

Gilead said it had resubmitted its application for a single-tablet combination of Truvada (emtricitabine and tenofovir disoproxil fumarate) and Johnson & Johnson subsidiary Tibotec Pharmaceuticals’ investigational drug TMC278 (rilpivirine hydrochloride) to treat HIV-1 infection in adults.